| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 09/27/2001 | CA2404253A1 Novel ecdysone receptor-based inducible gene expression system |
| 09/27/2001 | CA2404216A1 Novel polypeptides, and nucleic acids encoding the same |
| 09/27/2001 | CA2403815A1 An infective endogenous retrovirus in association with demyelinating diseases e.g. multiple sclerosis |
| 09/27/2001 | CA2403809A1 Angiogenesis - associated proteins, and nucleic acids encoding the same |
| 09/27/2001 | CA2403804A1 Vegf-modulated genes and methods employing them |
| 09/27/2001 | CA2403795A1 Osteocalcin promoter directed adenovirus replicaton for therapy |
| 09/27/2001 | CA2403760A1 Detection of immunological memory, t-cell conjugates for pathology imaging and therapy |
| 09/27/2001 | CA2403684A1 Therapeutic anti-melanoma compounds |
| 09/27/2001 | CA2403681A1 Therapeutic anti-cytomegalovirus compounds |
| 09/27/2001 | CA2403669A1 Methods and reagents for regulation of cellular responses in biological systems |
| 09/27/2001 | CA2403572A1 Fibroblast growth factor receptor-like molecules and uses thereof |
| 09/27/2001 | CA2403436A1 Acute neuronal induced calcium binding protein type 1 ligand |
| 09/27/2001 | CA2403434A1 Human gata-5 transcription factor |
| 09/27/2001 | CA2403162A1 Genetic silencing |
| 09/27/2001 | CA2402977A1 Methods for gamete production in birds |
| 09/27/2001 | CA2402763A1 Proteases |
| 09/27/2001 | CA2402747A1 G-protein associated molecules |
| 09/27/2001 | CA2402722A1 Sperm factor oscillogenin |
| 09/27/2001 | CA2402596A1 Anti-tissue factor antibodies with enhanced anticoagulant potency |
| 09/27/2001 | CA2402380A1 Leafy cotyledon2 genes and their uses |
| 09/27/2001 | CA2402266A1 Methods for transforming plant plastids and making transplastomic plants |
| 09/27/2001 | CA2401887A1 Nusap, a novel gene encoding a tissue-specific nuclear protein, useful as a diagnostic tool and therapeutic agent |
| 09/27/2001 | CA2400638A1 7 human ovarian and ovarian cancer associated proteins |
| 09/27/2001 | CA2374073A1 Novel polypeptides and nucleic acids encoding same |
| 09/26/2001 | EP1136823A2 Method for identifying and enriching cell specific target structures |
| 09/26/2001 | EP1136571A2 Detection of polymorphisms in the MxA gene to predict the response of an hepatitis C virus infected individual to interferon therapy |
| 09/26/2001 | EP1136558A1 Genetically modified plants and plant cells comprising heterologous heavy metal transport and complexation proteins |
| 09/26/2001 | EP1136553A1 Production of recombinant blood clotting factors in human cell lines |
| 09/26/2001 | EP1136548A1 Novel trypsin family serine proteases |
| 09/26/2001 | EP1136547A2 Adamts polypeptides, nucleic acids encoding them, and uses thereof |
| 09/26/2001 | EP1136504A1 Receptor for Latrotoxin from insects |
| 09/26/2001 | EP1136502A1 Insect ligand-gated anion channels |
| 09/26/2001 | EP1136501A2 Receptors for peptides from insect origin |
| 09/26/2001 | EP1135982A1 Method of constructing male sterile plant |
| 09/26/2001 | EP1135681A1 Three-hybrid screening method for ligand-protein interactions |
| 09/26/2001 | EP1135532A1 Fluorescent proteins from non-bioluminescent species of class anthozoa, genes encoding such proteins and uses thereof |
| 09/26/2001 | EP1135531A1 Methods for introducing heterologous cells into fish |
| 09/26/2001 | EP1135516A1 Use of an immuno complex for the preparation of a therapeutic composition useful for transfecting a polynucleotide into macropinocyte cells |
| 09/26/2001 | EP1135512A1 Artificial matrix attachment region for increasing expression of genes introduced in plant cells |
| 09/26/2001 | EP1135509A2 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 09/26/2001 | EP1135504A2 Human ubiquitin ligase e3 for the modulation of nf-kappa b |
| 09/26/2001 | EP1135503A2 DRUG TARGETS IN $i(CANDIDA ALBICANS) |
| 09/26/2001 | EP1135501A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 09/26/2001 | EP1135500A1 Control of flowering |
| 09/26/2001 | EP1135498A1 Antibody variants with higher binding affinity compared to parent antibodies |
| 09/26/2001 | EP1135496A2 Ucp5 |
| 09/26/2001 | EP1135495A2 Secreted amd transmembrane polypeptides and nucleic acids encoding the same |
| 09/26/2001 | EP1135494A2 Neuron-associated proteins |
| 09/26/2001 | EP1135491A2 Methods and compositions for inhibiting neoplastic cell growth |
| 09/26/2001 | EP1135490A1 Human vanilloid receptors and their uses |
| 09/26/2001 | EP1135489A1 Pth1r and pth3r receptors |
| 09/26/2001 | EP1135485A2 Promotion or inhibition of angiogenesis and cardiovascularization |
| 09/26/2001 | EP1135484A2 Gtpase associated proteins |
| 09/26/2001 | EP1135483A2 Cytokine signal regulators |
| 09/26/2001 | EP1135482A1 Cancer cell vaccine |
| 09/26/2001 | EP1135480A1 Promoters for gene expression in the roots of plants |
| 09/26/2001 | EP1135478A1 Activated cation channel of the osteoblast as a mechanism of bone anabolism |
| 09/26/2001 | EP1135477A1 Humanized monoclonal antibodies |
| 09/26/2001 | EP1135474A2 FATTY ACYL-CoA: FATTY ALCOHOL ACYLTRANSFERASES |
| 09/26/2001 | EP1135472A2 UDP-N- ACETYL GLUCOSAMINE: GALACTOSE-BETA1, 3-N- ACETYL GALACTOSAMINE-ALPHA-R/ N- ACETYL GLUCOSAMINE -BETA1, 3-N- ACETYL GALACTOSAMINE- ALPHA-R (GlcNAc TO GalNAc) BETA1, 6-N- ACETYL GLUCOSAMINYL TRANSFERASE, C2/4GnT |
| 09/26/2001 | EP1135470A2 Recombinant methods and materials for producing epothilone and epothilone derivatives |
| 09/26/2001 | EP1135469A1 An improved method for the production and purification of adenoviral vectors |
| 09/26/2001 | EP1135468A1 Virus vectors and methods of making and administering the same |
| 09/26/2001 | EP1135467A1 Psca: prostate stem cell antigen and uses thereof |
| 09/26/2001 | EP1135465A2 Human brain endothelial cells and growth medium and method for expansion of primitive cd34+cd38- bone marrow stem cells |
| 09/26/2001 | EP1135464A2 Periferal blood mensenchymal precursor cells |
| 09/26/2001 | EP1135463A2 Lymphoid tissue-specific cell production from hematopoietic progenitor cells in three-dimensional devices |
| 09/26/2001 | EP1135459A1 Method for culturing microorganisms in prefilled flexible containers |
| 09/26/2001 | EP1135412A2 Tumor necrosis factor receptor homologue-1 (trh1) |
| 09/26/2001 | EP1135411A1 Methods and compositions for treating disorders involving excitotoxicity |
| 09/26/2001 | EP1135407A1 Ring finger protein zapop3 |
| 09/26/2001 | EP1135177A1 Porous composite matrix and the production and use thereof |
| 09/26/2001 | EP1135158A2 Enhanced vaccines |
| 09/26/2001 | EP1135156A2 Medicinal product and method for treatment of conditions affecting neural stem cells or progenitor cells |
| 09/26/2001 | EP1135154A1 Improvement of folliculogenesis |
| 09/26/2001 | EP1135149A1 Pgc-1, a novel brown fat ppar gamma coactivator |
| 09/26/2001 | EP1135144A1 Compositions and methods for regulating bacterial pathogenesis |
| 09/26/2001 | EP1135114A1 Method for reducing free-radical induced injury |
| 09/26/2001 | EP1135026A1 Novel methods of protecting plants from pathogens |
| 09/26/2001 | EP0932664B1 A cell-free system for initiation of dna replication |
| 09/26/2001 | EP0909313A4 Methods for creating transgenic animals |
| 09/26/2001 | EP0831931A4 An in vivo and in vitro model of cutaneous photoaging |
| 09/26/2001 | EP0822839B1 Artificial skin containing as support biocompatible materials based on hyaluronic acid derivatives |
| 09/26/2001 | EP0495910B1 Production and use of human nm23-h2 protein and antibodies therefor |
| 09/26/2001 | CN1315000A Methods for determining presence of cancer in a sample by determining expression of an ssx gene, peptide derived from said ssx gene and NY-ESO-1 gene, and uses thereof |
| 09/26/2001 | CN1314953A Method and compositions to identify swine genetically resistant to F18 E. coli associated diseases |
| 09/26/2001 | CN1314952A Enzyme activity screen with direct substrate reloading |
| 09/26/2001 | CN1314950A Vitamin C production in microorganisms and plants |
| 09/26/2001 | CN1314945A DNA shuffling to produce herbicide selective crops |
| 09/26/2001 | CN1314944A Stress tolerance and delayed senesence in plants |
| 09/26/2001 | CN1314943A Method for producing plants with increased flavonoid and phenolic compound content |
| 09/26/2001 | CN1314939A Inhibition of graft versus host disease |
| 09/26/2001 | CN1314911A Optimization of pest resistance genes using DNA shuffling |
| 09/26/2001 | CN1314492A Method for simultaneously extracting pathogen RNA and DNA in body fluid and special extracting liquid thereof |
| 09/26/2001 | CN1314484A Suaeda salsa qlutathione s-transferase (GST) full length cDNA |
| 09/26/2001 | CN1314414A New activated T cell surface antigen of molecular weight 140 KDa |
| 09/26/2001 | CN1071791C DNA molecule for coding BSSL/CEL |
| 09/26/2001 | CN1071790C Variants of bile salt-stimulated lipase, its preparation, use and nucleic acid for coding it |
| 09/25/2001 | US6294716 Plants having modified response to ethylene by transformation with an ETR nucleic acid |
| 09/25/2001 | US6294714 Transforming plant cells using a vector containg a cytokinin synthesis gene as a selection marker controlled by a light-inducible promoter; selecting transgenic tissue based on morphology |